Millennium Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-447,128
Closed -$1.05M 6675
2024
Q3
$1.05M Sell
447,128
-40,034
-8% -$80.8K ﹤0.01% 4238
2024
Q2
$429K Sell
487,162
-557,806
-53% -$1.15M ﹤0.01% 4683
2024
Q1
$4.27M Buy
1,044,968
+649,054
+164% +$2.9M ﹤0.01% 3023
2023
Q4
$2.32M Buy
+395,914
New +$2.08M ﹤0.01% 3490
2022
Q2
Sell
-19,845
Closed -$58K 7655
2022
Q1
$58K Sell
19,845
-14,806
-43% -$40.2K ﹤0.01% 6354
2021
Q4
$109K Buy
+34,651
New +$126K ﹤0.01% 6221

Millennium Management's AUGX Position: Q4 2024 in Review

Millennium Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 447,128 shares — an estimated $1.05M sold.

Millennium Management first reported a position in AUGX in Q4 2021 and held it in 6 quarters. The position peaked at $4.27M in Q1 2024. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

  • Millennium Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Millennium Management sold 447,128 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $1.05M.
  • Millennium Management first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Millennium Management's Augmedix, Inc. Common Stock position peaked at $4.27M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on Millennium Management's 13F filing for Q4 2024, filed 14 Feb 2025.